Three types:
- Type I – quantitative reduction in glycoprotein αIIbβ3 levels (< 5%)
- Type II – quantitative reduction in glycoproteins αIIbβ3 levels (5%-20%)
- Type III – qualitative abnormalities that prevent function while allowing reduced or even normal platelet surface expression of glycoproteins αIIbβ3
Learn more here.